Reported Apr 15, 2026 · Ongoing
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc.,…
GE Healthcare Ireland Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: GE Healthcare Ireland Limited · Ida Business Park · Carrigtwohill · N/A
Is this the product you have?
- GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only
- Distributed byGE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91
- Lot codes and dates
12 of 12 products
Products covered by this recall # Product as published 1 Lot# 17333197 2 Exp. December 10, 2028 Lot# 17333198 3 Exp. November 17, 2028 Lot# 17396945 4 Exp. December 18, 2028 Lot# 17396948 5 Exp. December 22, 2028 Lot# 17396953 6 Exp. January 11, 2029 Lot# 17396956 7 Exp. January 9, 2029 Lot# 17423503 8 Exp. January 1, 2029 Lot# 17423525 9 Exp. January 3, 2029 Lot# 17426429 10 Exp. January 1, 2029 Lot# 17426440 11 Exp. January 4, 2029 Lot# 17431310 12 Exp. January 11, 2029 - Amount recalled
- 306,810 vials
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Where it was sold
- Nationwide
Why it was recalled
Presence of particulate matter
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new GE Healthcare Ireland Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.